This advert is not available!
Umeå University is one of Sweden’s largest higher education institutions with over 37,000 students and about 4,700 employees. The University offers a diversity of high-quality education and world-leading research in several fields. Notably, the groundbreaking discovery of the CRISPR-Cas9 gene-editing tool, which was awarded the Nobel Prize in Chemistry, was made here. At Umeå University, everything is close. Our cohesive campuses make it easy to meet, work together and exchange knowledge, which promotes a dynamic and open culture.
The ongoing societal transformation and large green investments in northern Sweden create enormous opportunities and complex challenges. For Umeå University, conducting research about – and in the middle of – a society in transition is key. We also take pride in delivering education to enable regions to expand quickly and sustainably. In fact, the future is made here.
Are you interested in learning more? Read about Umeå university as a workplace
The Faculty of Medicine, which consists of 12 departments, is responsible for biomedical research and courses in the field of nursing and health care and has an extensive research and graduate education in more than 80 subjects.
Position as research assistant with focus on amyotrophic lateral sclerosis
A position as research assistant at the Department Medical Biosciences is available for the study of the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Since 1993 internationally competitive interdisciplinary research with primary focus on the role of superoxide dismutase-1 (SOD1) in the pathogenesis of ALS has been conducted at Umeå University.
Description of the project
Earlier results from the group has identified neurotoxic effects of SOD1 as a central component of various types of ALS. Recently, we found that aggregates of SOD1, which arise in the CNS, can propagate further templated SOD1 aggregation in a prion-like manner and thereby cause ALS. The core of this project is to produce SOD1 aggregates/prions in vitro using CNS-derived aggregates as seeds. The pure in vivo-relevant SOD1 aggregates/prions are planned to be used for determination of molecular structures, for in vivo inoculation studies, and for production of prion-specific antibodies to be utilized for development of diagnostics and set the foundation for therapeutic development.
Project assignments
We are looking for a candidate that together with a supervisor and other coworkers in the group (PhD students, post docs, biomedical analysts, and senior scientists) has an interest to conduct science about ALS and other neurodegenerative diseases. Tasks mainly include participation in research projects with laboratory work (main focus on biochemical, molecular biology, and morphological techniques).
Competence requirements
Applicants must hold a Master of Science degree that covers biochemistry and immunology. Experience with HTS (High throughput screening) of drug candidates in a model system is required.
Very good knowledge in English, both written and spoken, is required. Also, very good knowledge in German, both written and spoken, is required to be part of collaboration with German research groups.
Other merits
The main focus of the laboratory work is based on protein biochemistry. Basic theoretical knowledge in biomedicine and protein biochemistry, gained through university studies or other equivalent education, as well as thorough experience in laboratory work (e.g. western blot, ELISA and other antibody based methods) is of high merit value. Work with animals and autopsy materials is planned. Practical experience of work with mice is of merit value. Documented experience with cell culture work is of merit value. Skills in bioinformatics is of merit value. Good knowledge about Excel and Adobe Creative Suite is of merit value. The applicant must be able to work both independently and as part of a team, with very high accuracy, and high focus will be given to the candidate’s potential collaborative skills.
Employment period
The position is full-time and is limited to six (6) months. The start date is as soon as possible or upon agreement.
Application procedure
The application must include the following documents:
Application, written in Swedish or English must be submitted via our e-recruitment system Varbi no later than 29 June 2020.
We look forward to receiving your application!
Type of employment | Permanent position |
---|---|
Contract type | Full time |
Number of positions | 1 |
Full-time equivalent | 100% |
City | Umeå |
County | Västerbottens län |
Country | Sweden |
Reference number | AN 2.2.1-838-20 |
Contact |
|
Union representative |
|
Published | 02.Jun.2020 |
Last application date | 29.Jun.2020 11:59 PM CEST |